id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1972-0007,FDA,FDA-2019-E-1972,Letter from FDA CDER TO U.S. Patent and Trademark Office,Other,Letter(s),2023-11-15T05:00:00Z,2023,11,2023-11-15T05:00:00Z,,2023-11-15T19:48:15Z,,0,0,090000648627c3a8
FDA-2019-E-1972-0006,FDA,FDA-2019-E-1972,Determination of Regulatory Review Period for Purposes of Patent Extension; OLUMIANT,Notice,Determinations,2023-02-06T05:00:00Z,2023,2,2023-02-06T05:00:00Z,2023-04-08T03:59:59Z,2024-02-07T15:45:24Z,2023-02441,0,0,0900006485633dbd
FDA-2019-E-1972-0005,FDA,FDA-2019-E-1972,Letter from FDA CDER to U. S. Patent and Trademark Office,Other,Letter(s),2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T15:41:10Z,,0,0,090000648562cb74